Alzheimer's disease

Gena Rowlands has Alzheimer’s, her son Nick Cassavetes says

Great Reads: Gleam of hope for Alzheimer’s prevention; Canada’s ballooning public sector; Ovechkin’s greatness

U.S. FDA delays decision on whether to approve Eli Lilly’s Alzheimer’s drug, calls for advisory panel

Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth

Researchers return to Alzheimer’s vaccines, buoyed by recent drug success

Biogen cuts annual profit forecast on Alzheimer’s drug launch, deal costs

Researcher Edith McGeer helped unravel mysteries of complex brain diseases

Some U.S. airports striving to make flying more inclusive for those with dementia

Wildfire smoke can damage the brain long after flames are extinguished, research says

Quest Diagnostics launches first direct-to-consumer Alzheimer’s blood test

Canadian Marc Tessier-Lavigne resigns as Stanford President after report finds research manipulation

Experimental Eli Lilly drug works best for Alzheimer’s patients treated as early as possible

Alzheimer’s diagnosis revamp embraces rating scale similar to cancer

U.S. FDA grants standard approval of Eisai/Biogen Alzheimer’s drug

Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use

Lilly drug slows Alzheimer’s by 35 per cent, bolstering treatment approach

Mediterranean, MIND diets may protect the brain from Alzheimer’s dementia, study shows

Experts temper hope for new FDA-approved Alzheimer’s drug

Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug